Teleflex Incorporated Announces Pricing of $400 Million Senior Notes Offering
May 11 2016 - 7:01PM
Business Wire
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today
that it priced its offering of $400.0 million aggregate principal
amount of 4.875% senior notes due 2026 (the “Notes”) at an issue
price of 100.000%. The sale of the Notes is expected to close on
May 16, 2016, subject to customary closing conditions.
The Notes will be guaranteed by each of Teleflex’s existing and
future wholly-owned domestic subsidiaries that is a guarantor or
other obligor under its revolving credit facility and by certain of
Teleflex’s other wholly-owned domestic subsidiaries.
Teleflex intends to use the net proceeds from the offering to
repay approximately $393.0 million of borrowings under its
revolving credit facility.
J.P. Morgan and BofA Merrill Lynch are acting as joint
book-running managers for this offering.
The Notes will be issued pursuant to an effective shelf
registration statement filed with the Securities and Exchange
Commission (“SEC”) on Form S-3. The offering is being made only by
means of a prospectus supplement and accompanying prospectus. You
may obtain these documents for free by visiting EDGAR on the SEC
website at www.sec.gov. Alternatively, copies may also be obtained
from J.P. Morgan Securities LLC by calling (866) 803-9204, or from
Merrill Lynch, Pierce, Fenner & Smith Incorporated at 200 North
College Street, 3rd Floor, Charlotte, NC 28255-0001 Attn:
Prospectus Department or by e-mail at
dg.prospectus_requests@baml.com. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy
the Notes, nor shall there be any sale of the Notes, in any
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.
ABOUT TELEFLEX INCORPORATED
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation—a relentless pursuit of identifying unmet
clinical needs—to benefit patients and healthcare providers. Our
portfolio is diverse, with solutions in the fields of vascular and
interventional access, surgical, anesthesia, cardiac care, urology,
emergency medicine and respiratory care. Teleflex employees
worldwide are united in the understanding that what we do every day
makes a difference.
CAUTION CONCERNING FORWARD-LOOKING INFORMATION
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management’s current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our prospectus supplement and
accompanying prospectus and our filings with the SEC, including our
Annual Report on Form 10-K filed with the SEC on February 25, 2016
and quarterly report on Form 10-Q filed with the SEC on April 28,
2016, which can be obtained on the SEC’s website at
http://www.sec.gov. We undertake no obligation to publicly update
or revise any forward-looking statements, except as otherwise
specifically stated by us or as required by law or regulation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160511006612/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Sep 2023 to Sep 2024